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Abstract
The complex spatial and paracrine relationships between the various liver
histotypes are essential for proper functioning of the hepatic parenchymal
cells. Only within a correct tissue organization, in fact, they stably maintain
their identity and differentiated phenotype. The loss of histotype identity,
which invariably occurs in the primary hepatocytes in culture, or in vivo in
particular pathological conditions (fibrosis and tumours), is mainly because
of the phenomenon of epithelial-to-mesenchymal transition (EMT). The
EMT process, that occurs in the many epithelial cells, appears to be driven by
a number of general, non-tissue-specific, master transcriptional regulators.
The reverse process, the mesenchymal-to-epithelial transition (MET), as yet
much less characterized at a molecular level, restores specific epithelial iden-
tities, and thus must include tissue-specific master elements. In this review,
we will summarize the so far unveiled events of EMT/MET occurring in liver
cells. In particular, we will focus on hepatocyte and describe the pivotal role
in the control of EMT/MET dynamics exerted by a tissue-specific molecular
mini-circuitry. Recent evidence, indeed, highlighted as two transcriptional
factors, the master gene of EMT Snail, and the master gene of hepatocyte dif-
ferentiation HNF4a, exhorting a direct reciprocal repression, act as pivotal
elements in determining opposite cellular outcomes. The different balances
between these two master regulators, further integrated by specific micro-
RNAs, in fact, were found responsible for the EMT/METs dynamics as well
as for the preservation of both hepatocyte and stem/precursor cells identity
and differentiation. Overall, these findings impact the maintenance of stem
cells and differentiated cells both in in vivo EMT/MET physio-pathological
processes as well as in culture.
The liver is one of the most complex organs, from both
a structural and functional standpoint. The physical
interactions between different cell types, arranged in
specific spatial relationships, are essential for proper
functioning of the parenchyma. This appears evident in
primary cultures, where the three-dimensional structure
of the organ and the interactions with the other hepatic
cell types are lost. Preserving liver cell differentiated
phenotype in vitro, thus, still represents a challenge
which is far from being overcome.
Hepatocytes, the major liver parenchymal cell type,
appear to be pivotal, together with the vascular tree,
for tissue organization and correct cross-talk between
different cell types. The mature hepatocytes, with their
arrangement in the liver lobule and paracrine activity,
are in fact essential for a correctly organized sinusoi-
dal system and control of the function of biliary cells
and hepatic stellate cells (HSCs). Endothelial cells,
cholangiocytes and stellate cells, in turn, are essential
for maintaining correct functionality of the hepato-
cyte. The importance of tissue architecture for correct
functioning of the liver is further demonstrated by
the phenomenon of liver zonation, in which hepato-
cytes display a metabolic specialization depending on
their localization in the liver lobule. The zonation is
related to large modulations of gene expression
induced by diffusible factors present in the liver lob-
ule according to concentration gradients along the
portal-venular axis (1). Recently, the Wnt pathway
has been unveiled as the main molecular signalling of
the liver zonation, and cross-talk between its down-
stream effectors and liver-specific transcriptional fac-
tors has been described (2).
In the adult liver, the hepatocyte stable identity is
challenged when the cells must undergo changes in
response to intrinsic and extrinsic signals, such as those
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inducing and driving the response to mitogens during
compensatory liver regeneration.
After loss of parenchyma (for surgical resection or
injuries caused by drugs, toxins or acute viral diseases),
virtually all residual hepatocytes, that in the normal
organ are nearly all quiescent, undergo 2–3 cell replica-
tions, completely recovering the original liver mass. This
liver compensatory regeneration is a rapid and tightly
orchestrated phenomenon, efficiently ensuring the reac-
quisition of original tissue functionality (3). Most
importantly, and differently from other cell types, in
which the proliferation and terminal differentiation are
mutually exclusive activities, in liver regeneration the
mature hepatocytes re-enter in cell cycle and proliferate
while maintaining the liver vital functions(4, 5). If start-
ing from this evidence it has been concluded that, essen-
tially, proliferating hepatocytes do not lose their
differentiated phenotype, a number of observations also
suggest as proliferation might imply the modulation of
some features towards a prenatal developmental stages;
in regenerating liver in fact: (i) the junctional complexes
of hepatocytes resemble the embryonic stages (6), (ii)
the transcriptional factor C/EBPa (known to peak
around birth, to decrease in the immediate neonatal
period and to rebound in the adult (7) is down-regu-
lated (8), (iii) subpopulations of hepatocytic cells
expressing Fn-14 and other progenitor markers are
detectable (9) and as recently reported, (iv) E-cadherin
is down-regulated (10). This appears consistent with
results obtained in in vitro models, where comparative
proteomic analysis indicates as the hepatocyte terminal
differentiation programme requires a quiescent state
maintained by cell–cell contact through the E-cadherin/
b-catenin pathway (11).
Liver cells undergo cellular transitions
The idea that terminal differentiation is permanently
maintained, once development is complete, has been
challenged by the observations that hepatocytes are
highly responsive to stimuli inducing profound cell
reprogramming and resulting in a mesenchymal trans-
differentiation by the process known as epithelial-to-
mesenchymal transition (EMT).
The EMT is a complex phenomenon by which several
types of epithelial polarized cells lose cell–cell connec-
tions and acquire mesenchymal characteristics of motil-
ity and invasiveness (12). Different EMT subtypes can
be categorized according to when this process occurs:
(i) type 1 concerns developmental and organogenesis
events; (ii) type 2 plays a major role in wound healing,
regeneration and fibrosis and (iii) type 3 characterizes
epithelial tumour progression rendering cancer cells
able to metastasize [for review (13)].
Hallmarks for EMT include increased expression of
vimentin, nuclear localization of b-catenin and produc-
tion of transcription factors able to inhibit E-cadherin
expression. In particular, master EMT inducers have
been identified in the transcriptional repressors belong-
ing to the Snail family, Snail (Snai1) and Slug (Snai2);
these factors are able to determine EMT induction tar-
geting many epithelial genes starting from the direct
inhibition of E-cadherin gene transcription(14). The
first indication that the Snail gene family had a key role
in triggering EMT, by loss-of-function experiments in
chick embryos (15), was successively confirmed in sev-
eral epithelial cell types and other vertebrate embryos
(16, 14). It is now widely demonstrated that Snail levels
are inversely correlated with E-cadherin in numerous
tumours and contribute to the acquisition of an invasive
phenotype (14, 16–19).
Many signalling pathways, including transforming
growth factor b (TGFb) superfamily, epidermal growth
factor (EGF), Wnt, sonic hedgehog (Hh) and Notch,
and oncogenic events, such as Src or Ras activation, are
implicated in EMT induction, both in physiology and
pathology (20, 21). Notably, Snail is the main effector of
many of these EMT inducers (22).
In particular, TGFb1 is considered the master EMT
inducer for malignant and non-malignant epithelial
cells, including hepatocytes (23). TGFb1 acts as a potent
inducer of EMT combining both Smad-dependent and
independent signalling pathways (24, 25). Binding of
TGFb1 with its receptors type I and type II induces
Smad2/3 phosphorylation. Phosphorylated Smads
recruit Smad4 to translocate into the nucleus and regu-
late gene expression. The activation of Snail promoter
depends on the direct binding of Smad3/Smad4 (26). In
turn, a complex between Snail and Smad3/Smad4
represses the epithelial markers E-cadherin and occludin
(26). TGFb also promotes EMT through activation of
MAPK, Rho GTPases and PI3K (24). Other EMT tran-
scriptional regulators, such as ZEB1, are also regulated
by TGFb1 in a Smad-dependent manner (24, 25). Nota-
bly, Snail (27) and ZEB1 (28) are able to repress miR-
200 family members, in turn targeting ZEB1 (29), and
thus controlling the EMT outcome by a feedback mech-
anism. Several other microRNAs and some ncRNAs,
with their ability to target multiple components
involved in epithelial integrity or mesenchymal traits,
recently emerged as potent regulators of EMT/MET
(30–32).
The EMT reverse transdifferentiation event, the mes-
enchymal-to-epithelial transition (MET), allows the
mesenchymal cells to redifferentiate into epithelial
structures. MET occurs in physiological (i.e. in develop-
ment) and pathological situations (i.e. cancer metasta-
sis), where the migrating mesenchymal-like cells that
have reached secondary sites reacquire cell–cell contacts
and polarity (33). Notably, an event of MET resulted
necessary for the success of experimentally induced cel-
lular reprogramming, where a cocktail of critical tran-
scriptional factors prompts fibroblasts to mimic
epithelial-like undifferentiated Embryonic Stem Cells
(ESC) (34, 35). Coherently with the fact that MET
represents a reversion of EMT, a down-regulation of
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EMT-inducing transcription factors such as Snail, Slug,
and ZEB1 is invariably associated with MET. As yet
MET molecular mechanisms are only partially charac-
terized.
It is conceivable that the MET process may involve a
number of histotype-specific elements, as suggested by
evidence revealing as the BMPs-dependent signalling
can promote MET in a histotype and context-specific
manner (24, 35).
The EMT/MET dynamics has also been proposed as a
key element of stem cell biology (36). In fact, a common
characteristic of embryonic and adult stem cells is the
presence of both epithelial and mesenchymal traits that
define the ‘metastable’ stem/precursor phenotype. A fine
regulated balance of EMT/MET dynamic allows for stem
cell self-renewal while its unbalance in either direction
causes generation of precursors that differentiate into
epithelial or mesenchymal cell types. The molecular
pathways controlling the EMT/MET dynamics of nor-
mal stem cells are expected to be similar to that of can-
cer stem cells, a specific population of metastable
tumour cells able to initiate and maintain many types of
cancer (37–39). Of note is the theoretical model for
molecular mechanisms controlling EMT/MET dynamics
based on the miR-34/Snail and the miR-200/Zeb
mutual-inhibition feedback circuits (40).
In the liver, several types of cells have been shown to
undergo EMT/MET: in particular, hepatocytes, both
primary and established in line, when treated with TGFb
down-regulate epithelial and hepatic markers (e-cadher-
in and albumin), while up-regulate mesenchymal genes
(vimentin and alpha-SMA) and acquire motility and
invasiveness (41–44). Valdes and colleagues (45)
reported that TGFb treatment of primary hepatocytes
selects an apoptosis-resistant cell population, which is
subjected to an EMT with an increase in Snail and
vimentin and negative regulation of E-cadherin,
cytokeratin 18 and hepatocyte nuclear factors (HNFs).
For most of these TGFb effects, the activation of Focal
Adhesion Kinase (FAK) signalling is required. TGFb, in
fact, induces a Src-dependent activation of FAK which
has been demonstrated to be necessary for (i) transcrip-
tional up-regulation of mesenchymal and invasiveness
markers and (ii) delocalization of membrane-bound
E-cadherin (46).
Moreover, the EMT process has been related to the
dedifferentiation process that invariably occurs in
freshly isolated hepatocytes within a few days of culture
on a stiff layer of dried collagen. Recently, the mecha-
nism controlling dedifferentiation of hepatocytes in pri-
mary cultures, in relation to the specific signalling
network triggered by extracellular matrix, has been par-
tially unveiled. In this case, a FAK-mediated AKT acti-
vation (promoting a resistance to the TGFb-induced
apoptosis) and ERK1/2 signalling activation (opening
the route to a TGFb-induced EMT programme)
were also observed. Antagonizing Akt and ERK1/2
signalling pathways caused the rescue of functional and
morphological features, thus unveiling a mechanism
controlling hepatocyte differentiation (47).
Cholangiocytes also transdifferentiate in mesenchy-
mal-like cells when treated with TGFb (48) or cultured
in medium conditioned by myofibroblasts derived from
fibrotic livers (49). Regarding HSCs, the liver cell type
that most contributes to liver fibrosis, they have been
suggested to be transitional cells. As a matter of fact
HSC retain precursor features in expressing a number of
epithelial and mesenchymal markers and appear able in
culture to become myofibroblasts by EMT or hepato-
cytes with a MET-like process (50).
With respect to the relevance of the EMT/MET phe-
nomena occurring in in vivo adult liver, the literature
collected evidence both for and against it. Concerning
the HSCs, if the idea that these are transitional cells,
expressing both mesenchymal and epithelial genes, is
accepted (50, 51), their activation into myofibroblasts,
largely observed during liver fibrosis, corresponds to an
EMT (51, 52). Instead, the possibility of HSCs undergo-
ing MET in vivo is most debatable. An elegant work by
Yang and collaborators (53), taking advantage of a
genetic cell lineage tracing, showed that HSCs, when
activated by liver injury or culture, became highly pro-
liferative and started to express mesenchymal and
epithelial markers. From these transitional cells, a popu-
lation of genetically marked hepatocytes, able to repop-
ulate large areas of the hepatic parenchyma, emerged.
Consistent with these results is the recent evidence, col-
lected by Conigliaro et al. (54), that metastable hepatic
stem/progenitor cells, isolated from embryonic livers
and established in clonally derived cell lines, give rise to
both hepatocytes and HSCs when injected into normal
growing liver.
Regarding hepatocytes, the results gathered by Zeis-
berg et al. (55), based on a lineage tracing approach in a
murine experimental model of liver fibrosis, suggested
that collagen producing cells can also be derived from
hepatocytes by EMT and that these types of myofibro-
blasts contribute significantly to the progression of liver
disease. However, Taura et al. (56) have followed, by a
similar approach of cell fate mapping, the outcome of
albumin expressing cells in injured liver, without identi-
fying hepatocyte-derived fibroblasts.
The Fig. 1 summarizes in a schematic representation
the physio-pathological EMT/MET dynamics of liver
cells.
EMT in hepatocytes implies down-regulation of
hepatic master gene HNF4a
The EMT in hepatocytes correlates with the down-regu-
lation of the hepatic differentiation key factors HNFs
(hepatocyte nuclear factors), particularly HNF4a.
Cicchini and colleagues demonstrated, indeed, that
the TGFb treatment of well-differentiated, non-tumo-
urigenic, hepatocytic cell lines (57) induces a full EMT,
underlined by Snail induction and E-cadherin, HNF1
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and HNF4a (43) down-regulation. Snail appears to be
at the cross-road of epithelial morphogenesis and differ-
entiation of hepatocyte. Snail overexpression, in fact,
appeared sufficient (i) to induce EMT in hepatocytes
(with conversion of morphology, down-regulation of
several epithelial adhesion molecules, reduction of pro-
liferation and induction of matrix metalloproteinase
two expression) and, most relevantly, (ii) to directly
repress the transcription of the HNF4a gene (43).
The liver-enriched transcriptional factor (LEFT)
HNF4a is a well-known master of both liver morpho-
genesis and hepatocyte differentiation. During embry-
onic development, a highly regulated network among a
number of LEFTs drives the differentiation process of
the endodermal stem cell in differentiated parenchymal
cells (58): HNF4a1, HNF1b, FoxA2, HNF6 and LRH-1
are key factors in this circuitry by acting as positive reg-
ulators of each other’s and of a repertoire of hepatic tar-
get genes. In particular, HNF1b, FoxA2 and HNF6 have
roles in controlling the onset of the hepatic gene expres-
sion during specification of the liver progenitors, while
HNF4a, although not having an impact on hepatic spec-
ification, is essential for subsequent differentiation of
hepatic progenitors. During midgestation, HNF4a
drives hepatocyte differentiation controlling the acquisi-
tion of an epithelial phenotype (59). This implies the
activation of the expression of cell adhesion and junc-
tion molecules that in turn convert non-polarized cells
in organized sheets of closely associated polarized epi-
thelial cells.
Concerning liver morphogenesis, when HNF4a is
specifically removed from foetal hepatoblasts, hepatic
architecture is severely affected, with livers exhibiting
loss of endothelial cells and disrupted hepatocellular
polarity (60). In adult hepatocytes, HNF4a continues to
have an important role in maintaining hepatocyte func-
tions (61, 62) and proliferative quiescence (63). This is
confirmed by genome-wide ChIP studies in which
HNF4a was found to occupy 12% of genes in human
adult hepatocytes (64).
Notably, an inverse correlation between HNF4a and
the EMT master factor Snail was demonstrated during
hepatocyte differentiation (65) and hepatocellular carci-
noma (HCC) progression. Snail expression, in fact, sig-
nificantly increases along with HCC dedifferentiation,
accelerating cancer invasion (66). Moreover, EMT and
E-cadherin down-regulation have been shown to play
an important role in HCC progression (67). On the
other hand, the loss of HNF4a expression is determi-
nant for HCC progression and its forced re-expression
is able to promote the highly invasive undifferentiated
tumour reversion towards a more differentiated epithe-
lium and the reacquisition of cell-ECM contacts (68).
Moreover, HCC cells expressing HNF4a also re-estab-
lished expression of the profile of liver transcription fac-
tors and hepatic genes that are associated with a
differentiated hepatocyte phenotype. Notably, HNF4a
overexpressing hepatoma cells are deficient for Snail,
expressed instead in the parental population (69).
All this evidence suggests that Snail could contribute
to liver tumour progression through the down-regula-
tion of HNF4a. This is in agreement with other observa-
tions that dedifferentiated hepatoma cell lines
constitutively express Snail, while well-differentiated rat
hepatoma cells are deficient for Snail (43).
HNF4a acts as a met master factor
Various evidences demonstrated a role for HNF4a as a
dominant regulator of the epithelial phenotype. Indeed,
HNF4a not only regulates the developmental expression
of adhesion molecules (60) but also when ectopically
expressed in different cells, such as fibroblast (59) and
F9 cells (70), it is sufficient to trigger tight-junction and
epithelial polarity molecules expression inducing a
MET.
Interestingly, HNF4a expression in dedifferentiated
hepatoma is sufficient to re-establish the hepatocyte
markers gene expression and epithelial cell morphology
and polarity (69). Moreover, in HCC the forced expres-
sion of HNF4a induces reversion of highly invasive
tumours towards a less invasive phenotype (68).
Notably, enforced expression of HNF4a, plus Foxa1,
Foxa2 or Foxa3, directly reprograms mouse fibroblasts
into induced hepatocyte-like (iHep) cells (71).
HNF4a controls hepatocyte epitheliality by active
repression of the mesenchymal programme
As mentioned above, the main HNF4a characterized
function was the positive modulation of tissue-specific
epithelial and hepatocyte gene expression, sufficient for
the acquisition of an epithelial differentiated phenotype.
Metastable cellsEpithelial cells Mesenchymal cells
RLSC
HSC
TransiƟonal cell
Fig. 1. Schematic representation of physio-pathological EMT/MET
dynamics of liver cells. Cells coexpressing epithelial/mesenchymal
markers are here termed ‘metastable’.
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Moreover, a new mechanism was recently unveiled by
which HNF4a, inducing MET maintains the hepato-
cyte-differentiated phenotype. Santangelo and col-
leagues (72), indeed, demonstrated a novel HNF4a
‘anti-mesenchymal’ role through the orchestrated
repression of both master EMT regulators and mesen-
chymal genes. These authors provided evidence of
repression of the mesenchymal programme, both during
the HNF4a-mediated MET process of undifferentiated
hepatoma or fibroblast cells, and in the normal fully dif-
ferentiated hepatocytes that stably retain the epithelial
phenotype. In particular, in dedifferentiated hepatoma,
forced expression of HNF4a appeared sufficient to
down-regulate mesenchymal markers such as Snail,
Slug, HMGA2, vimentin and fibronectin expression. In
terminally differentiated hepatocytes, endogenous
HNF4a was found stably recruited to the promoters of
these EMT inducers and mesenchymal genes. Using
both cell cultures and liver-specific HNF4a knockout
mouse models, a direct correlation between loss of
HNF4a and up-regulation of the mesenchymal genes
has been demonstrated. Histological examination of
liver sections from Alb-HNF4a -/- mice demonstrated
that hepatocytes, with the known hypertrophic pheno-
type, express vimentin, desmin, fibronectin and
a-smooth muscle actin (with no increase in non-paren-
chymal cells) (61,72).
These data integrate the well-established notion of
the pivotal positive role of HNF4a in hepatocyte differ-
entiation through expression of epithelial genes with the
new concept of an active and fundamental role of
HNF4a in the repression of the hepatocyte mesenchy-
mal programme.
The capacity of HNF4a-depleted hepatocyte to
acquire a mesenchymal phenotype is intriguing and
deserves future investigations on HNF4a KO models,
especially in the light of the reports suggesting that qui-
escent HSC might be transitional cells derived from the
partial EMT of epithelial cells (73). The evidence
reported by Santangelo and colleagues (72), together
with the previous demonstration that Snail directly
represses HNF4a (43), allows for the formulation of a
simple cross-regulatory model between Snail and
HNF4a: the expression of each factor is mutually exclu-
sive to the other, and this is because of the presence of
repressor elements in each promoter. This HNF4a/Snail
circuit of reciprocal regulation between two master reg-
ulators provides a simple molecular mechanism for
EMT/MET feedback and reversible differentiation pro-
cesses in both physiology and pathology.
Notably, the same authors extended the ‘anti-mesen-
chymal’ role of HNF4a, by direct transcriptional regula-
tion of EMT master genes and mesenchymal markers,
the other hepatocyte-enriched transcriptional factor
HNF1a (72), known to play an important role in hepa-
tocyte differentiation and function (64) and to be posi-
tively regulated by HNF4a. Successively, also Pelletier
and colleagues, providing evidence that HNF1a inhibi-
tion triggers EMT in human liver cell lines, concluded
that HNF1a has a role in the maintenance of hepatocyte
epithelial identity (74). Moreover, was reported to be
one of the few factors which ectopic expression in
embryonic fibroblasts (MEFs) appears sufficient to gen-
erate induced hepatocyte-like (iHep) cells (75).
Thus, both HNF4a and HNF1a transcriptional
repression of critical mesenchymal genes is pivotal, not
only for the regulation of the dynamic process of MET
but also for the maintenance of a stable epithelial phe-
notype.
SNAIL/HNF4a circuit also plays a pivotal role in
liver stem cell maintenance
Several recent studies showed how the induction of
EMT in differentiated epithelial cells corresponds to the
execution of a stemness programme. In particular, an
important work of Mani and collaborators showed that
treatment with TGFb of immortalized cells of mammary
epithelium, as well as ectopic expression of two master
genes of the EMT, Twist or Snail, induces, together with
a mesenchymal phenotype, the expression of stem cell
markers and the ability to form mammospheres, as
mammary epithelial stem cells do (76). Similarly, the
treatment of tumoural mammary epithelial cells, allows
for the acquisition of a cancer stem cell behaviour, such
as the formation of mammospheres, the capacity to
form colonies on soft-agar and increased efficiency of
tumour formation. Also Morel et al. (77), using a mam-
mary tumour progression model, showed that the
acquisition of stem and tumourigenic characteristics of
cancer stem cells are driven by EMT induction.
Moreover, the coexpression of epithelial and mesen-
chymal markers in the epithelial stem cells characterized
so far, suggests that the maintenance of a partial mesen-
chymal programme could be necessary for stemness
behaviour.
In line with this observation is the finding that Snail
is expressed in hepatic stem/precursor cells resident in
the murine livers and that this expression correlates with
the expression of stemness markers (27). This unex-
pected finding, considering that the transcriptional
repression is the only function so far attributed to Snail,
allowed for identifying other factors integrating/mediat-
ing Snail activity. In particular, it has been shown that
in liver stem/precursor cells, Snail inhibits the hepato-
specific programme through direct repression of the
HNF4a gene and the epithelial microRNAs (miR)-200c
and 34a, known as stemness-inhibiting microRNAs for
their targeting of stemness genes, while in the hepato-
cytes, HNF4a, together with a direct repression of Snail
gene, directly up-regulates miR-200 family members
(200a, b and c) and miR-34a transcription, thus further
stabilizing the hepatocytic phenotype. Altogether, these
data unveiled Snail, HNF4a and miRNAs as elements
controlling hepatic stem cell maintenance/differentia-
tion, acting in a simple and direct molecular mini-cir-
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cuitry in which master elements reciprocally repress
their own expression while inversely controlling the
expression of specific microRNAs.
HNF4a as a gene therapy tool for HCC
As mentioned above, the emergence of mesenchymal
traits characterizes cells metastasizing from carcinomas
and during HCC progression, an inverse regulation
between Snail and HNF4a is observed with Snail expres-
sion directly correlating with the dedifferentiation grade
of HCC, cancer invasion and poor prognosis (66). In a
comparable way, HNF4a expression, lost in more
aggressive HCC, if restored, promotes reversion towards
a less invasive phenotype, both repressing EMT pro-
gramme and promoting hepatocyte differentiation (69,
78). Therefore, the restoration of the functions HNF4a
in HCC invasive represents an important milestone for
the anticancer therapies. However, recent data have
shown that in an environment containing TGFb,
HNF4a restoration usually fails to counteract tumour
progression. The tumour promotion effects of TGFb,
indeed, result dominant on HNF4a activity, thus limit-
ing the HNF4a gene transfer as a therapeutic approach
of HCC.
The molecular basis of this dominance resides on
some post-translational modifications, induced by the
TGFb signalling on HNF4a protein, that provoke the
displacement of transcriptional factor from its target
gene promoters, including Snail. GSK3b kinase has been
individuated as one of the TGFb targets mediating
HNF4a functional inactivation; GSK3b chemical inhibi-
tion, in fact, resulted in the HNF4a DNA binding
impairment, while a constitutively active GSK3b mutant
impairs the TGFb-induced inhibitory effect on HNF4a
tumour suppressor activity (79).
Conclusions and perspectives
The balance between Snail (EMT master gene) and
HNF4a (MET master gene) in liver stem cells and liver
cancer cells (cancer stem cells or transformed hepato-
cytes) ultimately influences the outcome of the transi-
tion between the mesenchymal/undifferentiated and the
epithelial/differentiated phenotype. This simple and
direct molecular mini-circuitry of master elements
(Fig. 2), able to reciprocally repress their own expres-
sion may theoretically provide the best device to trigger
complex phenomena such as stemness and differentia-
tion. However, this necessarily implies that these master
factors act in much more complex macromolecular sys-
tems, able to direct and modulate a whole transcrip-
tional profile, influencing the early stages of gene
expression.
Further studies are necessary to shed light on the
complexity of the cellular output of the proposed mini-
circuitry, based on the conceivable hypothesis that a
transcriptional master gene acts by organizing a molecu-
lar platform that in turn is capable of driving a coherent
cellular response which involves hundreds of target
genes. In other terms, both the EMT/stemness master
regulator Snail and the MET/hepatocyte differentiation
master regulator HNF4a could behave as reprogram-
ming transcriptional factors, triggering the necessary
epigenetic changes on regulative regions of their own
target genes. As ‘master’ regulators of stem cell fate and/
or the reprogramming of a differentiated cell, they could
directly recruit general chromatin modifiers to their tar-
get genes, regulating their transcriptional competency.
Moreover, we believe that the hierarchical relevance
of these master regulatory molecules, controlling a
broad range of cellular functions, may allow for design-
ing simple molecular therapies based on a gene transfer
approach. The epistatic relation among Snail/HNF4a, a
number of miRNAs and their target genes, is further
influenced by environmental cues such as TGFb.
In this context, the use of engineered molecular tools,
insensitive to negative regulation by the microenviron-
ment, will represent the successful approach to improve
gene therapy strategies.
Although promising in in vitro and preclinical stud-
ies, this strategy, when applied clinically, should take
into account the tumour niche influence, which is capa-
ble of exerting direct functional impairment of thera-
peutic molecules.
Mesenchymality
migraƟon
stemness
EMT MET
Epitheliality
liver funcƟons
SNAIL HNF4α
Stem and mesenchymal genes
Micro-RNAs
Fig. 2. Molecular circuitry controlling EMT/MET liver cell dynamics.
The balance between Snail and HNF4a, based on their mutual neg-
ative regulation, controls epitheliality, mesenchymality and stem-
ness of liver cells. A number of microRNAs were found to amplify
the biological impacts of the circuitry.
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